SYAM Trademark

Trademark Overview


On Tuesday, August 1, 2023, a trademark application was filed for SYAM with the United States Patent and Trademark Office. The USPTO has given the SYAM trademark a serial number of 98112142. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, October 28, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The SYAM trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, namely, multifunctional molecules that promote binding to immune cells and disease cells or organisms, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Discovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
syam

General Information


Serial Number98112142
Word MarkSYAM
Filing DateTuesday, August 1, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements


Goods and ServicesPharmaceutical products, namely, multifunctional molecules that promote binding to immune cells and disease cells or organisms, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders
Goods and ServicesDiscovery, research, development, engineering, and testing of pharmaceuticals and substances, namely, functional molecules that promote binding to immune cells and disease cells, for use in the treatment of autoimmune disorders, inflammatory diseases and conditions, metabolic disorders, allergies, cancers, infectious diseases, and neurological disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 30, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG

Trademark Events


Event DateEvent Description
Friday, August 4, 2023NEW APPLICATION ENTERED
Wednesday, August 30, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 23, 2023ASSIGNED TO EXAMINER
Monday, September 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, January 5, 2024ASSIGNED TO EXAMINER
Tuesday, April 2, 2024SOU EXTENSION 1 FILED
Tuesday, April 2, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024SOU EXTENSION 2 GRANTED
Monday, October 28, 2024SOU EXTENSION 2 FILED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 2, 2024SOU EXTENSION 1 GRANTED